previous next

Can changes to prescription labels and other public standards help tame the opioid crisis?

The opioid crisis in the U.S. seems to be part of nearly every news broadcast and news site today. And based on the number of people affected by this crisis, serious conversations about how to help are more important than ever. The CDC estimates that more than 100 Americans die every day from an opioid overdose. And nearly 12 million people – close to 4% of the U.S.

Share

Generic drugs: New approaches to maximize competition, lower prices and increase access

Generic drugs

Building the marketplace for generic medicines is a key strategy to containing drug costs in the US, one that USP actively supports through our standards-setting work.

Tags: Generics
Share

Pages

Related Stories

Increasing the sources of quality medicines in LMICs: Challenges and strategies
Increasing the sources of quality medicines in LMICs: Challenges and strategies
USP Excipient Monographs & Standards
USP Excipient Monographs & Standards
Characterization of Biologics: USP Standards
Medicine Quality Assurance: USP's Technical Review Program